People: Maria L. Maebius, Counsel

Photo of Maria L. Maebius, Counsel

Maria L. Maebius

Counsel

Washington, D.C.
Direct: (202) 772-9723
0
Maria Maebius is counsel in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. Ms. Maebius focuses on a wide variety of biotechnological and chemical inventions, including modified nucleic acids, sequencing methods, stem cell differentiation, pharmaceutical delivery systems including transduced autologous cells, and immunological systems. Throughout her career as a patent attorney, she has worked on both sides of patents, including the preparation and prosecution of patent applications as well as reviewing and analyzing issued patents in developing litigation strategies or opinions relating thereto.
 
She has experience in the management of patent portfolios of a variety of companies, including small start-ups, and medium to large biopharmaceutical companies. She has experience developing offensive and defensive patenting strategies, performing intellectual property audits to assess strengths and weakness of existing intellectual property, and preparing and prosecuting foreign and domestic patent applications. Ms. Maebius is a proponent of the proactive analyses of competitive pending patent applications to allow companies to stay of its competitors. Additionally, she is experienced in preparing non-infringement and invalidity opinions and post-issuance patent proceedings, including reexaminations, reissue, and interference proceedings.
 
Ms. Maebius has assisted clients on the business side of patents, including patent valuations; review of license, non-disclosure, material transfer and cooperative research agreements; compliance with government licenses; and risk analyses, including freedom-to-operate and landscape analyses. In addition, she has assisted in the merger and acquisition of a start-up company into a publicly traded biotechnology company managing the patent portfolio, reviewing the transfer agreement, and coordinating the review and analysis of intellectual property assets.
 
Prior to joining the firm, Ms. Maebius was a partner at a large international law firm in Washington, D.C., a student associate of a leading D.C. intellectual property boutique, and an Examiner in the biotechnology art unit of the United States Patent and Trademark Office (USPTO).
Maria Maebius is counsel in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. Ms. Maebius focuses on a wide variety of biotechnological and chemical inventions, including modified nucleic acids, sequencing methods, stem cell differentiation, pharmaceutical delivery systems including transduced autologous cells, and immunological systems. Throughout her career as a patent attorney, she has worked on both sides of patents, including the preparation and prosecution of patent applications as well as reviewing and analyzing issued patents in developing litigation strategies or opinions relating thereto.
 
She has experience in the management of patent portfolios of a variety of companies, including small start-ups, and medium to large biopharmaceutical companies. She has experience developing offensive and defensive patenting strategies, performing intellectual property audits to assess strengths and weakness of existing intellectual property, and preparing and prosecuting foreign and domestic patent applications. Ms. Maebius is a proponent of the proactive analyses of competitive pending patent applications to allow companies to stay of its competitors. Additionally, she is experienced in preparing non-infringement and invalidity opinions and post-issuance patent proceedings, including reexaminations, reissue, and interference proceedings.
 
Ms. Maebius has assisted clients on the business side of patents, including patent valuations; review of license, non-disclosure, material transfer and cooperative research agreements; compliance with government licenses; and risk analyses, including freedom-to-operate and landscape analyses. In addition, she has assisted in the merger and acquisition of a start-up company into a publicly traded biotechnology company managing the patent portfolio, reviewing the transfer agreement, and coordinating the review and analysis of intellectual property assets.
 
Prior to joining the firm, Ms. Maebius was a partner at a large international law firm in Washington, D.C., a student associate of a leading D.C. intellectual property boutique, and an Examiner in the biotechnology art unit of the United States Patent and Trademark Office (USPTO).

Education

  • J.D., The George Washington University Law School

  • B.S. in Biology, The Ohio State University

Admissions

  • District of Columbia
  • Virginia
  • Registered Patent Attorney, U.S. Patent and Trademark Office

Courts

  • Court of Appeals for the Federal Circuit

Affiliations

  • Court-Appointed Special Advocate, Fairfax County, Virginia 2016

Representative Engagements

  • Assisted in the acquisition of PhosImmune by Agenus Inc. (2015)
  • Eli Lilly & Co. v Board of Regents of the University of Washington (Fed. Cir. 2003) – assisted in the successful patent strategy and Federal Circuit appeal preventing the institution of an interference.